Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 1
1991 3
1992 5
1993 2
1994 4
1995 3
1996 5
1997 8
1998 7
1999 10
2000 8
2001 9
2002 4
2003 3
2004 5
2005 2
2006 2
2007 1
2008 1
2009 2
2010 1
2017 2
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
The in vitro pharmacological characterization of naloxone benzoylhydrazone.
Berzetei-Gurske IP, White A, Polgar W, DeCosta BR, Pasternak GW, Toll L. Berzetei-Gurske IP, et al. Eur J Pharmacol. 1995 Apr 24;277(2-3):257-63. doi: 10.1016/0014-2999(95)00088-3. Eur J Pharmacol. 1995. PMID: 7493617
On the basis of its in vivo activity and binding affinity, naloxone benzoylhydrazone has been characterized as a kappa 3-opioid receptor agonist and a mu-opioid receptor antagonist. ...As an antagonist, naloxone benzoylhydrazone is similar to naloxone, …
On the basis of its in vivo activity and binding affinity, naloxone benzoylhydrazone has been characterized as a kappa 3-opioi …
Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP. Chiou LC, et al. Curr Drug Targets. 2007 Jan;8(1):117-35. doi: 10.2174/138945007779315605. Curr Drug Targets. 2007. PMID: 17266536 Review.
These include N/OFQ-derived peptides acting as agonists (cyclo[Cys(10),Cys(14)]N/OFQ, [Arg(14), Lys(15)]N/OFQ, [pX]Phe(4)N/OFQ(1-13)-NH(2), UFP-102, [(pF)Phe(4),Aib(7), Aib(11),Arg(14),Lys(15)]N/OFQ-NH(2)) or antagonists (Phe(1)psi(CH(2)-NH)Gly(2)]N/OFQ(1-13)-NH(2), [Nphe(1)]N/OF …
These include N/OFQ-derived peptides acting as agonists (cyclo[Cys(10),Cys(14)]N/OFQ, [Arg(14), Lys(15)]N/OFQ, [pX]Phe(4)N/OFQ(1-13)-NH(2), …
Naloxone benzoylhydrazone (NalBzoH) analgesia.
Paul D, Levison JA, Howard DH, Pick CG, Hahn EF, Pasternak GW. Paul D, et al. J Pharmacol Exp Ther. 1990 Nov;255(2):769-74. J Pharmacol Exp Ther. 1990. PMID: 2173757
Naloxone benzoylhydrazone (NalBzoH) is a novel mixed agonist/antagonist. ...
Naloxone benzoylhydrazone (NalBzoH) is a novel mixed agonist/antagonist. ...
Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
Flau K, Redmer A, Liedtke S, Kathmann M, Schlicker E. Flau K, et al. Br J Pharmacol. 2002 Dec;137(8):1355-61. doi: 10.1038/sj.bjp.0704998. Br J Pharmacol. 2002. PMID: 12466246 Free PMC article.
Ac-RYYRIK-NH(2) 0.032 microM did not affect the evoked overflow by itself whereas naloxone benzoylhydrazone 5 microM inhibited it in each tissue. 3. The electrically evoked tritium overflow from mouse brain cortex slices preincubated with [(3)H]-noradrenaline was in …
Ac-RYYRIK-NH(2) 0.032 microM did not affect the evoked overflow by itself whereas naloxone benzoylhydrazone 5 microM inhibited …
Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
Standifer KM, Murthy LR, Kinouchi K, Steele L, Pasternak GW. Standifer KM, et al. Mol Pharmacol. 1991 Mar;39(3):290-8. Mol Pharmacol. 1991. PMID: 1848652
Naloxone benzoylhydrazone (NalBzoH) labels both mu and kappa receptors in standard homogenate binding assays. ...
Naloxone benzoylhydrazone (NalBzoH) labels both mu and kappa receptors in standard homogenate binding assays. ...
Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC. Chiou LC. Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):583-9. doi: 10.1007/s002100100402. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11414652
Although initially developed as an opioid receptor ligand, naloxone benzoylhydrazone (NalBzOH) is one of the few antagonists at ORL1. ...
Although initially developed as an opioid receptor ligand, naloxone benzoylhydrazone (NalBzOH) is one of the few antagonists a …
Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.
Werthwein S, Bauer U, Nakazi M, Kathmann M, Schlicker E. Werthwein S, et al. Br J Pharmacol. 1999 May;127(1):300-8. doi: 10.1038/sj.bjp.0702534. Br J Pharmacol. 1999. PMID: 10369486 Free PMC article.
Nociceptin also inhibited the evoked overflow in mouse cerebellar, hippocampal and hypothalamic slices in a manner sensitive to naloxone benzoylhydrazone. The electrically (3 Hz) evoked tritium overflow in mouse cortex slices preincubated with [3H]-serotonin was inh …
Nociceptin also inhibited the evoked overflow in mouse cerebellar, hippocampal and hypothalamic slices in a manner sensitive to naloxone …
Naloxone benzoylhydrazone, a kappa 3 opioid agonist, stimulates food intake in rats.
Koch JE, Pasternak GW, Arjune D, Bodnar RJ. Koch JE, et al. Brain Res. 1992 May 29;581(2):311-4. doi: 10.1016/0006-8993(92)90723-m. Brain Res. 1992. PMID: 1327401
Naloxone benzoylhydrazone (NalBzoH) is a selective, short-acting agonist at the kappa 3 opioid receptor and a slowly dissociating potent antagonist at the mu opioid receptor. ...
Naloxone benzoylhydrazone (NalBzoH) is a selective, short-acting agonist at the kappa 3 opioid receptor and a slowly dissociat …
Ligand based conformational space studies of the μ-opioid receptor.
Sena DM Jr, Cong X, Giorgetti A. Sena DM Jr, et al. Biochim Biophys Acta Gen Subj. 2021 Mar;1865(3):129838. doi: 10.1016/j.bbagen.2020.129838. Epub 2020 Dec 26. Biochim Biophys Acta Gen Subj. 2021. PMID: 33373630
METHODS: MOR was modeled in complex with agonists (morphine, BU72), a partial agonist (naloxone benzoylhydrazone) and an antagonist (naloxone). Replica exchange with solute tempering (REST2) molecular dynamics simulations were carried out for all systems. ...
METHODS: MOR was modeled in complex with agonists (morphine, BU72), a partial agonist (naloxone benzoylhydrazone) and an antag …
88 results